The potential of 3′, 5′-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant

W Chen, R KuoLee, H Yan - Vaccine, 2010 - Elsevier
3′, 5′-Cyclic diguanylic acid (c-di-GMP) is a bacterial intracellular signaling molecule that
plays a crucial role in the regulation of bacterial motility, adhesion, cell-to-cell …

Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers

NK Garg, S Mangal, H Khambete… - Recent Patents on …, 2010 - ingentaconnect.com
Majority of infectious microorganism make their gateway to the host through mucosal
surfaces, such as gastrointestinal tract, nasal and vaginal tract. Mucosal immune response …

Nasolacrimal Duct Closure Modulates Ocular Mucosal and Systemic CD4+ T-Cell Responses Induced following Topical Ocular or Intranasal Immunization

AA Chentoufi, G Dasgupta, AB Nesburn… - Clinical and Vaccine …, 2010 - Am Soc Microbiol
Both topical ocular and topical intranasal immunizations have been reported to stimulate the
ocular mucosal immune system (OMIS) and the systemic immune system. Nasolacrimal …

Heat-labile enterotoxins as adjuvants or anti-inflammatory agents

S Liang, G Hajishengallis - Immunological investigations, 2010 - Taylor & Francis
Escherichia coli and Vibrio cholerae produce structurally related AB5-type heat-labile
enterotoxins, which are classified into two major types. The Type I subfamily includes …

Recent advances in the development of novel mucosal adjuvants and antigen delivery systems

W Chen, GB Patel, H Yan, J Zhang - Human vaccines, 2010 - Taylor & Francis
Mucosal infections and associated diseases remain a major socio-economic burden to
society. Since parenteral immunizations fail to induce efficient protective immunity at …

Combined mucosal and systemic immunity following pulmonary delivery of ISCOMATRIX™ adjuvanted recombinant antigens

A Vujanic, JLK Wee, KJ Snibson, S Edwards, M Pearse… - Vaccine, 2010 - Elsevier
Deep pulmonary delivery of an influenza ISCOMATRIX™ vaccine has previously been
shown to induce a combined mucosal and systemic antibody response. To explore whether …

Mucosal HIV vaccines: a holy grail or a dud?

A Azizi, H Ghunaim, F Diaz-Mitoma, J Mestecky - Vaccine, 2010 - Elsevier
The mucosal immune system appears to be a major target of the HIV infection. Therefore, a
strong pre-existing anti-HIV immune response in mucosal compartments might be able to …

Nasal vaccination with P6 outer membrane protein and α-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated …

K Noda, S Kodama, S Umemoto, N Abe, T Hirano… - Vaccine, 2010 - Elsevier
The efficacy of α-galactosylceramide (α-GalCer) as a mucosal adjuvant was examined. Mice
were immunized intranasally with nontypeable Haemophilus influenzae (NTHi) P6 protein …

Oral immunization with Porphyromonas gingivalis outer membrane protein and CpG oligodeoxynucleotides elicits T helper 1 and 2 cytokines for enhanced protective …

C Liu, T Hashizume, T Kurita‐Ochiai… - Molecular oral …, 2010 - Wiley Online Library
The aim of this study was to evaluate the efficacy of an oral vaccine containing the 40‐kDa
outer membrane protein of Porphyromonas gingivalis (40K‐OMP) and synthetic …

Protection against Naegleria fowleri infection in mice immunized with Cry1Ac plus amoebic lysates is dependent on the STAT6 Th2 response

M Carrasco‐Yepez… - Parasite …, 2010 - Wiley Online Library
We previously reported that intranasal administration of Cry1Ac protoxin alone or in
combination with amoebic lysates increases protection against Naegleria fowleri …